跳至主要内容
临床试验/NCT02122237
NCT02122237已完成3 期

Cathodal Transcranial Direct Current Stimulation in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

University of Liege2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
14
试验地点
2
主要终点
Migraine frequency

研究概览

简要总结

Cathodal tDCS decreases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in chronic migraine.

详细描述

During the interictal phase, the cerebral cortex is characterised by a hyperresponsiveness to repeated sensory stimuli, manifested by a lack of habituation or adaptation of cortical responses. Lack of habituation has been shown in the visual cortex in studies of visual evoked potentials (VEP) during the interictal period and it is possibly explained by a reduction in the cortical pre-activation level due to thalamo-cortical dysrhythmia. Just before and during the migraine attack, cortical reactivity changes drastically: habituation is restored and the amplitude increases. In chronic migraine (headache occurring on 15 or more days per month for more than 3 months with features of migraine headache on at least 8 days per month), VEPs habituate normally like those recorded during attacks of episodic migraine, but have in addition an increased amplitude in the 1st block of responses. Chronic migraine was therefore compared to a "never ending migraine attack" accompanied by cortical hypersensitivity.

In this study the investigators aim to demonstrate that cathodal tDCS over the visual cortex with simultaneous anodal tDCS over the left dorsolateral prefrontal cortex is able: 1) to reduce cortical hypersensitivity and habituation as assessed by VEPs and contact heat evoked nociceptive potentials (CHEPS), as well as to decrease pain perception assessed by quantitative sensory testing (QST) and the nociceptive blink reflex (nBR); 2) to decrease headache and migraine frequency.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse

排除标准

  • others diseases or contraindications to tDCS (epilepsy, pacemaker, metal prosthetics)

结局指标

主要结局

Migraine frequency

时间窗: 6 months

The investigators evaluate migraine frequency at baseline, during the treatment and 2 months after its end.

次要结局

  • Migraine intensity(6 months)
  • Attack duration(6 months)
  • Scores at psychological scales(6 months)
  • Acute medication intake(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean Schoenen

Honorary Full Professor

University of Liege

研究点 (2)

Loading locations...

相似试验